AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 145 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $280,091,012 | -19.9% | 6,090,259 | +0.0% | 0.01% | -20.0% |
Q2 2023 | $349,890,407 | +42.1% | 6,088,227 | -7.3% | 0.01% | +42.9% |
Q1 2023 | $246,265,353 | +24.9% | 6,567,076 | -6.7% | 0.01% | +16.7% |
Q4 2022 | $197,226,307 | -1.8% | 7,038,769 | -1.5% | 0.01% | -14.3% |
Q3 2022 | $200,854,000 | -18.4% | 7,147,813 | +1.1% | 0.01% | -12.5% |
Q2 2022 | $246,042,000 | -3.5% | 7,072,197 | -0.4% | 0.01% | +14.3% |
Q1 2022 | $255,016,000 | +52.9% | 7,103,524 | -0.8% | 0.01% | +75.0% |
Q4 2021 | $166,771,000 | +22.2% | 7,160,665 | -0.2% | 0.00% | 0.0% |
Q3 2021 | $136,446,000 | -6.9% | 7,177,581 | -1.3% | 0.00% | 0.0% |
Q2 2021 | $146,557,000 | +8.4% | 7,269,619 | -1.5% | 0.00% | 0.0% |
Q1 2021 | $135,150,000 | -5.9% | 7,377,178 | +3.3% | 0.00% | -20.0% |
Q4 2020 | $143,669,000 | +11.0% | 7,144,166 | +3.5% | 0.01% | 0.0% |
Q3 2020 | $129,439,000 | -12.8% | 6,903,389 | +4.4% | 0.01% | -16.7% |
Q2 2020 | $148,505,000 | +61.2% | 6,611,928 | +6.5% | 0.01% | +20.0% |
Q1 2020 | $92,115,000 | -22.1% | 6,207,165 | +1.2% | 0.01% | 0.0% |
Q4 2019 | $118,287,000 | -0.5% | 6,132,054 | +2.3% | 0.01% | 0.0% |
Q3 2019 | $118,897,000 | -5.0% | 5,995,824 | +1.2% | 0.01% | 0.0% |
Q2 2019 | $125,124,000 | +4.9% | 5,927,141 | +1.5% | 0.01% | 0.0% |
Q1 2019 | $119,312,000 | +1.2% | 5,840,034 | -1.5% | 0.01% | -16.7% |
Q4 2018 | $117,946,000 | +2.4% | 5,926,878 | -1.0% | 0.01% | +20.0% |
Q3 2018 | $115,205,000 | +32.0% | 5,987,805 | +4.7% | 0.01% | +25.0% |
Q2 2018 | $87,291,000 | -13.8% | 5,720,183 | +5.9% | 0.00% | -20.0% |
Q1 2018 | $101,284,000 | -4.5% | 5,401,823 | -2.0% | 0.01% | 0.0% |
Q4 2017 | $106,106,000 | +7.7% | 5,514,765 | +0.0% | 0.01% | 0.0% |
Q3 2017 | $98,508,000 | +2.2% | 5,512,455 | +2.2% | 0.01% | 0.0% |
Q2 2017 | $96,355,000 | +20.4% | 5,394,972 | -2.2% | 0.01% | +25.0% |
Q1 2017 | $80,026,000 | +173869.6% | 5,519,038 | +224342.4% | 0.00% | – |
Q4 2016 | $46,000 | -6.1% | 2,459 | -5.6% | 0.00% | – |
Q3 2016 | $49,000 | +32.4% | 2,605 | +14.5% | 0.00% | – |
Q2 2016 | $37,000 | -15.9% | 2,276 | -37.8% | 0.00% | – |
Q1 2016 | $44,000 | +340.0% | 3,658 | +396.3% | 0.00% | – |
Q4 2015 | $10,000 | +11.1% | 737 | 0.0% | 0.00% | – |
Q3 2015 | $9,000 | -30.8% | 737 | 0.0% | 0.00% | – |
Q2 2015 | $13,000 | – | 737 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
LAM GROUP, INC. | 130,250 | $3,649,605 | 3.75% |
SHAKER INVESTMENTS LLC/OH | 81,287 | $2,277,662 | 1.41% |
Mesirow Institutional Investment Management, Inc. | 374,414 | $10,491,080 | 1.38% |
OBERWEIS ASSET MANAGEMENT INC/ | 134,000 | $3,754,680 | 0.80% |
Portolan Capital Management | 270,791 | $7,587,564 | 0.75% |
Hillsdale Investment Management Inc. | 172,238 | $4,826,109 | 0.41% |
Capital Impact Advisors, LLC | 14,669 | $411,025 | 0.40% |
Watershed Asset Management, L.L.C. | 9,555 | $267,731 | 0.34% |
Quantedge Capital Pte Ltd | 35,153 | $984,987 | 0.33% |
FEDERATED HERMES, INC. | 3,284,217 | $92,023,760 | 0.25% |